Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Malignant Melanoma

Free Subscription Articles published in Eur J Dermatol Retrieve available abstracts of 59 articles: HTML format

Single Articles

August 2024
1. CAYUELA L, Pereyra-Rodriguez JJ, Hernandez-Rodriguez JC, Sendin-Martin M, et al
   Non-melanoma skin cancer burden in Spain: a nationwide analysis of incidence trends (1990-2019).
   Eur J Dermatol. 2024;34:392-397.
   PubMed     Abstract available
   
   
   June 2024
2. YOON S, Lee SY, Lee GJ, Kim JS, et al
   Psoriasis and in situ or invasive non-melanoma skin cancer: a bidirectional Mendelian randomisation study.
   Eur J Dermatol. 2024;34:314-317.
   PubMed    
   
   
   April 2024
3. PARK YJ, Baek DJ, Kim DC, Kim YC, et al
   A case of pigmented Bartholin cyst mimicking mucosal melanoma.
   Eur J Dermatol. 2024;34:205-207.
   PubMed    
   
   
   
4. RAVNI E, Skowron F, David C, Cortez CD, et al
   Correlation between super-high magnification (400x) dermoscopy and reflectance confocal microscopy for the diagnosis of melanosis and other pigmented genital lesions.
   Eur J Dermatol. 2024;34:131-138.
   PubMed     Abstract available
   
   
   December 2023
5. SONG T, Tan C, Liu Y, Xue YN, et al
   Dermoscopic and reflectance confocal microscopy features of Netherton syndrome.
   Eur J Dermatol. 2023;33:696-697.
   PubMed    
   
   
   
6. LANGBOUR C, Law-Wan J, Ben-Saad R, Zaragoza J, et al
   Intramedullary spinal cord metastasis: a rare complication of malignant melanoma.
   Eur J Dermatol. 2023;33:694-696.
   PubMed    
   
   
   October 2023
7. FUKUCHI K, Shimauchi T, Fujiyama T, Ito T, et al
   A case of bullous pemphigoid in a malignant melanoma patient following an increased Th2/Th1 ratio in peripheral blood cells after nivolumab treatment.
   Eur J Dermatol. 2023;33:550-551.
   PubMed    
   
   
   
8. KIM PJ, Lansang RP, Ko E, Abu-Hilal M, et al
   Incidence of melanoma and non-melanoma skin cancer in patients with celiac disease: a systematic review and meta-analysis.
   Eur J Dermatol. 2023;33:506-513.
   PubMed     Abstract available
   
   
   
9. VAN DIEREN L, Amar JZ, Geurs N, Quisenaerts T, et al
   Unveiling the power of convolutional neural networks in melanoma diagnosis.
   Eur J Dermatol. 2023;33:495-505.
   PubMed     Abstract available
   
   
   June 2023
10. SAMELA T, Fania L, Sampogna F, Mastroeni S, et al
    Incidence of keratinocyte carcinomas in Italy: an exercise in indirect estimation based on melanoma data.
    Eur J Dermatol. 2023;33:230-234.
    PubMed     Abstract available
    
    
    
11. IBRAHIM N, Ali SR, Dobbs TD, Gibson AGJ, et al
    The incidence of non-melanoma skin cancer in the UK and the Republic of Ireland: a systematic review.
    Eur J Dermatol. 2023;33:218-229.
    PubMed     Abstract available
    
    
    April 2023
12. GARCIA-PIQUERAS P, Aviles-Izquierdo JA
    Clues in Dermoscopy. Epidermotropic cutaneous malignant melanoma metastases: a description of 25 cases.
    Eur J Dermatol. 2023;33:190-192.
    PubMed    
    
    
    
13. PIROTH M, Goronflot T, Samaran R, Varey E, et al
    Panniculitis does not predict clinical response in patients with advanced melanoma under targeted therapy.
    Eur J Dermatol. 2023;33:126-136.
    PubMed     Abstract available
    
    
    
14. BELLINATO F, Moar A, Rosina P, Gisondi P, et al
    Comparative dermoscopy assessment of nevus-associated versus de novo in situ melanoma.
    Eur J Dermatol. 2023;33:121-125.
    PubMed     Abstract available
    
    
    
15. CHARPENTIER C, Riche VP, Nguyen JM, Guile R, et al
    Analysis of cost-effectiveness of chemotherapeutic agents and new therapies for the management of unresectable and metastatic melanoma.
    Eur J Dermatol. 2023;33:81-86.
    PubMed     Abstract available
    
    
    
16. FRENARD C, Blanchet K, Lecerf P, Varey E, et al
    Machine learning algorithm to predict response to immunotherapy in real-life settings for patients with advanced melanoma.
    Eur J Dermatol. 2023;33:75-80.
    PubMed     Abstract available
    
    
    November 2022
17. ECKARDT J, Behrens V, Kofler K, Forchhammer S, et al
    The impact of haematoxylin-eosin staining and immunohistochemistry of lentigo maligna and lentigo maligna melanoma margins on local recurrence.
    Eur J Dermatol. 2022;32:750-755.
    PubMed     Abstract available
    
    
    
18. ZOUTENDIJK J, Siem D, Argenziano G, Forsea AM, et al
    The daily use of dermoscopy in the Netherlands.
    Eur J Dermatol. 2022;32:736-742.
    PubMed     Abstract available
    
    
    
19. L'ORPHELIN JM, Le Naour S, Dalle S, Varey E, et al
    Epidemiology and characteristics of acral lentiginous melanoma compared to lentigo melanoma in France: a multicentric retrospective study from the French cohort RIC-Mel database.
    Eur J Dermatol. 2022;32:691-697.
    PubMed     Abstract available
    
    
    
20. RICCI F, Fania L, Antonelli F, Ricci F, et al
    Melanoma on tattoos: a case study and review of the literature.
    Eur J Dermatol. 2022;32:703-708.
    PubMed     Abstract available
    
    
    
21. PAPANIKOLAOU ES, Sampogna F, Fania L, Di Lella G, et al
    Quality of life in caregivers of melanoma patients.
    Eur J Dermatol. 2022;32:698-702.
    PubMed     Abstract available
    
    
    September 2022
22. SPURNY-DWORAK J, Steiner A, Breier F, Stella A, et al
    Effects of the COVID-19 pandemic on the diagnosis of malignant melanoma: a retrospective study.
    Eur J Dermatol. 2022;32:615-617.
    PubMed     Abstract available
    
    
    July 2022
23. TEUSCHER M, Diehl K, Schaarschmidt ML, Weilandt J, et al
    Effects of the COVID-19 pandemic on care of melanoma patients in Berlin, Germany: the Mela-COVID survey
    Eur J Dermatol. 2022;31:521-529.
    PubMed     Abstract available
    
    
    
24. GAMO-VILLEGAS R, Floristan-Muruzabal U, Pampin-Franco A, Martin-Alcalde J, et al
    Dermoscopic changes in 22 extrafacial in situ and invasive lentiginous melanomas
    Eur J Dermatol. 2022;32:516-521.
    PubMed     Abstract available
    
    
    May 2022
25. YANG L, Wang T, Liu YH
    A Chinese case of amelanotic lentigo maligna melanoma
    Eur J Dermatol. 2022;32:410-411.
    PubMed    
    
    
    April 2022
26. SUHONEN V, Siiskonen H, Suni M, Rummukainen J, et al
    Malignant and in situ subtypes of melanoma are associated with basal and squamous cell carcinoma and its precancerous lesions
    Eur J Dermatol. 2022;32:187-194.
    PubMed     Abstract available
    
    
    February 2022
27. SUYAMA T, Nishimura T, Yokoyama M, Matsuki Y, et al
    Paediatric spitzoid melanoma diagnosed with the aid of fluorescence in situ hybridization and mutation analysis.
    Eur J Dermatol. 2022 Feb 15. pii: ejd.2022.4208. doi: 10.1684/ejd.2022.4208.
    PubMed    
    
    
    
28. AMABILE S, Tonella L, Rubatto M, Argenziano G, et al
    Clinical evaluation of hydration index using a corneometer in metastatic melanoma patients treated with BRAF/MEK inhibitors: a prospective study.
    Eur J Dermatol. 2022 Feb 11. pii: ejd.2022.4198. doi: 10.1684/ejd.2022.4198.
    PubMed    
    
    
    January 2022
29. SUYAMA T, Nishimura T, Yokoyama M, Matsuki Y, et al
    Paediatric spitzoid melanoma diagnosed with the aid of fluorescence.
    Eur J Dermatol. 2022;32:134-135.
    PubMed    
    
    
    
30. AMABILE S, Tonella L, Rubatto M, Argenziano G, et al
    Clinical evaluation of hydration index using a corneometer in metastatic melanoma patients treated with BRAF/MEK inhibitors: a prospective study.
    Eur J Dermatol. 2022;32:126-127.
    PubMed    
    
    
    
31. SUYAMA T, Nishimura T, Yokoyama M, Matsuki Y, et al
    Paediatric spitzoid melanoma diagnosed with the aid of fluorescence.
    Eur J Dermatol. 2022;32:134-135.
    PubMed    
    
    
    
32. AMABILE S, Tonella L, Rubatto M, Argenziano G, et al
    Clinical evaluation of hydration index using a corneometer in metastatic melanoma patients treated with BRAF/MEK inhibitors: a prospective study.
    Eur J Dermatol. 2022;32:126-127.
    PubMed    
    
    
    December 2021
33. DUARTE AF, Sousa-Pinto B, Azevedo LF, Barros AM, et al
    Clinical ABCDE rule for early melanoma detection.
    Eur J Dermatol. 2021;31:771-778.
    PubMed     Abstract available
    
    
    
34. LACOMBE M, Bedane C, Delaumenie S, Bernard P, et al
    Nivolumab-induced multiple morphea associated with eosinophilic fasciitis.
    Eur J Dermatol. 2021;31:844-846.
    PubMed    
    
    
    November 2021
35. RUBIO-CASADEVALL J, Carbo-Bague A, Puigdemont M, Osca-Gelis G, et al
    Population-based analysis of the prevalence of BRAF mutation in patients diagnosed with cutaneous melanoma and its significance as a prognostic factor.
    Eur J Dermatol. 2021 Nov 17. pii: ejd.2021.4136. doi: 10.1684/ejd.2021.4136.
    PubMed     Abstract available
    
    
    
36. BUJA A, De Luca G, Zorzi M, Carpin E, et al
    Quality management of cutaneous melanoma: impact on short-term outcomes and costs.
    Eur J Dermatol. 2021 Nov 17. pii: ejd.2021.4149. doi: 10.1684/ejd.2021.4149.
    PubMed     Abstract available
    
    
    October 2021
37. MAEDA T, Hiura A, Uehara J, Toyoshima R, et al
    Real-world efficacy of nivolumab plus ipilimumab combination therapy versus nivolumab monotherapy for Stage IV melanoma patients in Asia.
    Eur J Dermatol. 2021 Oct 7. pii: ejd.2021.4139. doi: 10.1684/ejd.2021.4139.
    PubMed    
    
    
    
38. GARCIA-PIQUERAS P, Aviles-Izquierdo JA, Almodovar-Real A, Nieto-Benito LM, et al
    Clues in dermoscopy: White and yellow structures in balloon cell melanoma.
    Eur J Dermatol. 2021;31:676-677.
    PubMed    
    
    
    
39. NEUBERGER A, Menzer C, Volk N, Enk AH, et al
    Expression of p53 up-regulated modulator of apoptosis (PUMA) in non-melanoma skin cancer of long-term immunosuppressed solid organ transplant recipients compared to immunocompetent patients.
    Eur J Dermatol. 2021;31:609-615.
    PubMed     Abstract available
    
    
    August 2021
40. SENDIN-MARTIN M, Duran-Romero AJ, Martin-Carrasco P, Conejo-Mir J, et al
    Mortality associated with non-melanoma skin cancer in Spain from 1979 to 2018: trends and age-adjusted rates.
    Eur J Dermatol. 2021 Aug 26. pii: ejd.2021.4110. doi: 10.1684/ejd.2021.4110.
    PubMed     Abstract available
    
    
    
41. ARAUJO BLC, De Oliveira JL, Correa FM, Fontes LES, et al
    General anaesthesia versus other types of anaesthesia in patients undergoing surgery for treatment of cutaneous melanoma: a systematic review and meta-analysis.
    Eur J Dermatol. 2021 Aug 26. pii: ejd.2021.4109. doi: 10.1684/ejd.2021.4109.
    PubMed     Abstract available
    
    
    
42. TEUSCHER M, Diehl K, Schaarschmidt ML, Weilandt J, et al
    Effects of the COVID-19 pandemic on care of melanoma patients in Berlin, Germany: the Mela-COVID survey.
    Eur J Dermatol. 2021 Aug 26. pii: ejd.2021.4098. doi: 10.1684/ejd.2021.4098.
    PubMed     Abstract available
    
    
    
43. BOADA A, Tejera-Vaquerizo A, Requena C, Manrique-Silva E, et al
    Association between melanoma thickness and clinical and demographic characteristics.
    Eur J Dermatol. 2021 Aug 26. pii: ejd.2021.4096. doi: 10.1684/ejd.2021.4096.
    PubMed     Abstract available
    
    
    
44. DONZEL M, Harou O, Skowron F, Dalle S, et al
    Acral lentiginous melanoma with HER2/ErbB2 amplification.
    Eur J Dermatol. 2021;31:588-590.
    PubMed    
    
    
    
45. GEDEAH C, Damsin T, Absil G, Somja J, et al
    The impact of COVID-19 on the new diagnoses of melanoma.
    Eur J Dermatol. 2021;31:565-567.
    PubMed    
    
    
    
46. SAMARAN R, L'Orphelin JM, Dreno B, Rat C, et al
    Interest in artificial intelligence for the diagnosis of non-melanoma skin cancer: a survey among French general practitioners.
    Eur J Dermatol. 2021;31:457-462.
    PubMed     Abstract available
    
    
    June 2021
47. ARNE V, Canan G, Marjan G
    A narrative review on the outcome of primary cutaneous melanomas arising in solid organ transplant recipients.
    Eur J Dermatol. 2021 Jun 2. pii: ejd.2021.4067. doi: 10.1684/ejd.2021.4067.
    PubMed     Abstract available
    
    
    
48. POZSGAI M, Nemeth K, Olah P, Gyulai R, et al
    The significance of imaging examinations during follow-up for malignant melanoma.
    Eur J Dermatol. 2021;31:357-363.
    PubMed     Abstract available
    
    
    
49. MASSON L, Poizeau F
    sQuiz your knowledge! A cutaneous nodule in an HIV-positive man returning from Thailand.
    Eur J Dermatol. 2021;31:436-437.
    PubMed    
    
    
    April 2021
50. BANCALARI B, Ferrer-Guillen S, Tejera-Vaquerizo A, Requena C, et al
    Longitudinal study of prognostic factors for localized cutaneous melanoma in patients who have been disease-free for five years.
    Eur J Dermatol. 2021 Apr 19. pii: ejd.2021.4022. doi: 10.1684/ejd.2021.4022.
    PubMed     Abstract available
    
    
    
51. SCARD C, Nguyen JM, Varey E, Moustaghfir I, et al
    Cardiac adverse events associated with anti-PD-1 therapy in patients treated for advanced melanoma: relevance of dosing troponin T levels.
    Eur J Dermatol. 2021 Apr 2. pii: ejd.2021.4009. doi: 10.1684/ejd.2021.4009.
    PubMed     Abstract available
    
    
    
52. JOVIC A, Tiodorovic D, Popovic D, Vidovic N, et al
    Multiple eruptive squamous cell carcinomas: a possible clinical sign in melanoma patients treated with vemurafenib.
    Eur J Dermatol. 2021;31:279-280.
    PubMed    
    
    
    
53. KACZMARCZYK R, King F, Tizek L, Biedermann T, et al
    Visualising the past to plan the future: a network analysis of the largest European dermatology conference.
    Eur J Dermatol. 2021;31:161-169.
    PubMed     Abstract available
    
    
    
54. RODRIGUEZ-LOMBA E, Lozano-Masdemont B, Sanchez-Herrero A, Suarez-Fernandez R, et al
    Dermsurgery: Reconstruction of a large dorsal hand defect with a dermal substitute matrix.
    Eur J Dermatol. 2021;31:302-304.
    PubMed    
    
    
    March 2021
55. MILLAN-ESTEBAN D, Garcia-Casado Z, Manrique-Silva E, Viros A, et al
    Distribution and clinical role of KIT gene mutations in melanoma according to subtype: a study of 492 Spanish patients.
    Eur J Dermatol. 2021 Mar 1. pii: ejd.2021.3971. doi: 10.1684/ejd.2021.3971.
    PubMed     Abstract available
    
    
    February 2021
56. RUSSO I, Filoni A, Alaibac M
    Persistence of superficial basal cell carcinoma during pembrolizumab treatment for metastatic melanoma.
    Eur J Dermatol. 2021 Feb 12. pii: ejd.2020.3958. doi: 10.1684/ejd.2020.3958.
    PubMed    
    
    
    December 2020
57. LUDWIG SV, F Cheng P, Mangana J, Braun R, et al
    Survival and therapeutic response in patients with melanoma of unknown and known primary: a single-centre retrospective analysis.
    Eur J Dermatol. 2020;30:699-709.
    PubMed     Abstract available
    
    
    November 2020
58. MORA-FERNANDEZ V, Boada A, Manzano JL, Jaka A, et al
    Locally advanced head and neck squamous cell carcinoma and melanoma simultaneously treated with pembrolizumab: an unusual situation.
    Eur J Dermatol. 2020 Nov 24. pii: ejd.2020.3911. doi: 10.1684/ejd.2020.3911.
    PubMed    
    
    
    October 2020
59. GRAN F, Weber J, Schummer P, Kneitz H, et al
    Sarcoidosis developing upon immune checkpoint inhibition in advanced uveal melanoma.
    Eur J Dermatol. 2020;30:629-631.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge.